Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piers Whitehead

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Vaccine|February 19, 2013
Active immunotherapy for chronic diseasesMartin F Bachmann, Piers Whitehead
Medecine Sciences : M/S|October 24, 2013
[Anti-viral treatment: pro or cons type I IFN?]Piers Whitehead, Béatrice Drouet, Daniel Zagury, et al.
Allergy|August 27, 2024
On the role of antibody affinity and avidity in the IgE-mediated allergic responseMartin F Bachmann, Pascal S Krenger, Mona O Mohsen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Vaccine|February 19, 2013
Active immunotherapy for chronic diseasesMartin F Bachmann, Piers Whitehead
Medecine Sciences : M/S|October 24, 2013
[Anti-viral treatment: pro or cons type I IFN?]Piers Whitehead, Béatrice Drouet, Daniel Zagury, et al.
Allergy|August 27, 2024
On the role of antibody affinity and avidity in the IgE-mediated allergic responseMartin F Bachmann, Pascal S Krenger, Mona O Mohsen, et al.
Pageof 1